The therapeutic effect of gelatin tannate in acute diarrhea in children

Turkish Journal of Pediatrics

Volumn 59, Issue 5, 2017, Pages 531-536

  Kara, Soner Sertan ^a   Volkan, Burcu ^b   Erten, İbrahim ^c  

^a Divisions of Pediatric Infectious Diseases   (Turkey)

^b Unit of Pediatric Gastroenterology Hepatology and Nutrition   (Turkey)

^c Regional Training and Research Hospital ^*  (Turkey)

Author keywords

Acute diarrhea; Children; Gelatin tannate; Rotavirus

Indexed keywords

GELATIN; MALTODEXTRIN; ORAL REHYDRATION SOLUTION; TASECTAN; ZINC; ANTIDIARRHEAL AGENT; TANNATE GELATIN; TANNIN DERIVATIVE;

ACUTE DIARRHEA; ADENOVIRIDAE; ARTICLE; BODY WEIGHT GAIN; BRISTOL SCORE; CHILD; CLINICAL DEHYDRATION SCALE; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NOROVIRUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; SINGLE BLIND PROCEDURE; VOMITING; ACUTE DISEASE; BODY WEIGHT; DIARRHEA; FECES; GASTROENTERITIS; MICROBIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIDIARRHEALS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DIARRHEA; FECES; FEMALE; GASTROENTERITIS; GELATIN; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TANNINS; TREATMENT OUTCOME;

EID: 85046271576     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: 10.24953/turkjped.2017.05.005     Document Type: Article

References (21)

1. Baker T. Burden of community diarrhoea in developing countries. Lancet Glob Health 2016; 4: e25.
2. Wiegering V, Kaiser J, Tappe D, Weissbrich B, Morbach H, Girschick HJ. Gastroenteritis in childhood: A retrospective study of 650 hospitalized pediatric patients. Int J Infect Dis 2011; 15: e401-e407.
3. Platts-Mills JA, Babji S, Bodhidatta L, et al. Pathogen-specific burdens of community diarrhoea in developing countries: A multisite birth cohort study (MAL-ED). Lancet Glob Health 2015; 3: e564-e575.
4. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; CD003048.
5. Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. J Pediatr Gastroenterol Nutr 2014; 59: 132-152.
6. Cruchet S, Furnes R, Maruy A, et al. The use of probiotics in pediatric gastroenterology: A review of the literature and recommendations by Latin-American experts. Paediatr Drugs 2015; 17: 199-216.
7. Ruszczyński M, Urbańska M, Szajewska H. Gelatin tannate for treating acute gastroenteritis: A systematic review. Ann Gastroenterol 2014; 27: 121-124.
8. Esteban Carretero J, Durbán Reguera F, López-Argüeta Alvarez S, López Montes J. A comparative analysis of response to ORS (oral rehydration solution) vs. ORS + gelatin tannate in two cohorts of pediatric patients with acute diarrhea. Rev Esp Enferm Dig 2009; 101: 41-48.
9. King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: Oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52: 1-16.
10. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-924.
11. Allegrini A, Costantini M. Gelatine tannate for the treatment of acute diarrhoea in adults. J Gastroint Dig Syst 2012; 2: 3.
12. Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012; 12: 395-410.
13. Feizizadeh S, Salehi-Abargouei A, Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 2014; 134: e176-e191.
14. Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013; 38: 467-476.
15. Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN Working Group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr 2014; 58: 531-539.
16. Dinleyici EC, PROBAGE Study Group, Vandenplas Y. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr 2014; 103: e300-e305.
17. Dinleyici EC, Dalgic N, Guven S, et al. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J) 2015; 91: 392-396.
18. Bueno L. Mechanisms involved in bacterial pathogen-induced intestinal mucosal barrier disruption: Therapeutic interest of physical protection of epithelial tight junction. WebEx Conference, June 25, 2014.
19. Scaldaferri F, Lopetuso LR, Petito V, et al. Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? United European Gastroenterol J 2014; 2: 113-122.
20. Bernstein DI. Rotavirus overview. Pediatr Infect Dis J 2009; 28: S50-S53.
21. Ahmadi E, Alizadeh-Navaei R, Rezai MS. Efficacy of probiotic use in acute rotavirus diarrhea in children: A systematic review and meta-analysis. Caspian J Intern Med 2015; 6: 187-195.